Back to Search
BARBARA GLISSON, PH.D.
PH.D.
Psychologist
NPI: 1629115647Individual
Specialties, Licenses & Credentials
PsychologistPrimary
Psychologist
Code: 103T00000X
PSY13190(CA)
Research & Publications (20)
HER2 expression in salivary gland carcinomas: dependence on histological subtype.
PMID 14871971·Clin Cancer Res·2004
3-trial
Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.
PMID 11896109·J Clin Oncol·2002
3-trial
The role of docetaxel in the management of squamous cell cancer of the head and neck.
PMID 12108901·Oncology (Williston Park)·2002
6-review
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.
PMID 10944132·J Clin Oncol·2000
3-trial
A phase II study of Lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neck.
PMID 19433965·Am J Clin Oncol·2009
3-trial
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.
PMID 19289628·J Clin Oncol·2009
8-other
Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.
PMID 19564532·J Clin Oncol·2009
3-trial
IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
PMID 18556144·Int J Radiat Oncol Biol Phys·2009
8-other
Dose escalation of gemcitabine is possible with concurrent chest three-dimensional rather than two-dimensional radiotherapy: a phase I trial in patients with stage III non-small-cell lung cancer.
PMID 18556142·Int J Radiat Oncol Biol Phys·2009
3-trial
Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study.
PMID 18429002·Cancer·2008
4-observational
Dose-dependent and sequence-dependent cytotoxicity of erlotinib and docetaxel in head and neck squamous cell carcinoma.
PMID 18418213·Anticancer Drugs·2008
8-other
Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer.
PMID 17762342·J Thorac Oncol·2007
3-trial
Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program.
PMID 16640804·Clin Lung Cancer·2006
4-observational
Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma.
PMID 16342249·Cancer·2006
3-trial
Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.
PMID 16943532·J Clin Oncol·2006
3-trial
Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma.
PMID 16028213·Cancer·2005
3-trial
Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series.
PMID 16086413·Head Neck·2005
8-other
A phase I/II study of neoadjuvant chemotherapy followed by radiation with boost chemotherapy for advanced T-stage nasopharyngeal carcinoma.
PMID 16199307·Int J Radiat Oncol Biol Phys·2005
3-trial
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.
PMID 16258975·Cancer·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4088 BRIDGE ST STE 3
FAIR OAKS, CA 95628 - Phone
- (916) 967-1042
Quick Facts
- NPI
- 1629115647
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile